F
$ Value
$96
Shares
17
Price
$6
Filed
Jan 16
Insider
Name
Conway Kevin John
Title
Chief Financial Officer
CIK
0002051408
Roles
Officer
Transaction Details
Transaction Date
2026-01-15
Code
F
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
1,909
Footnotes
Each restricted stock unit represents the right to receive one share of the company's common stock. | The grant of 9,390 restricted stock units was made on January 20, 2023. The shares underlying the restricted stock units vest over four years, with 25% of the shares vested on January 15, 2024 and the remaining shares vesting in equal quarterly installments thereafter.
Filing Info
Conway Kevin John's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-02-09 | GBIO | U | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
| 2026-02-09 | GBIO | D | — |
Other Insiders at GBIO (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
| JONAS JEFFREY M | — | — | 2026-02-09 |
| Rowland Charles A Jr | — | — | 2026-02-09 |
| Christensen Gustav | — | — | 2026-02-09 |
| Quinn Anthony G. | — | — | 2026-02-09 |
| Rhodes Jason P | — | — | 2026-02-09 |
| Atlas Venture Fund X, L.P. | — | — | 2026-02-09 |
| Cooper Ronald Harold Wilfred | — | — | 2026-02-09 |
| Stehman-Breen Catherine | — | — | 2026-02-09 |
| MCDONOUGH GEOFF | — | — | 2026-02-09 |
| Nicholson Donald William | — | — | 2026-02-09 |
|
Howze Yalonda
INTERIM CEO & PRESIDENT
|
— | — | 2026-02-02 |
|
Howze Yalonda
INTERIM CEO AND PRESIDENT
|
— | — | 2026-02-09 |
| Appelhans Dannielle | — | — | 2026-02-09 |
|
Conway Kevin John
CHIEF FINANCIAL OFFICER
|
— | — | 2026-02-09 |
|
Conway Kevin John
Chief Financial Officer
|
— | — | 2026-02-02 |